Upgrade to SI Premium - Free Trial

Acumen Pharmaceuticals, Inc (ABOS)

1.96 -0.10 (4.85%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (10/26/26)

Latest Headlines

Acumen Pharmaceuticals to present Phase 2 trial data at CTAD October 22, 2026 7:30 AM - StreetInsider Acumen Pharmaceuticals to Present Preliminary Baseline Characteristics and Data on Care Experiences and Participation in Phase 2 ALTITUDE-AD Trial at the 19th Annual Clinical Trials on Alzheimer’s D October 22, 2026 7:30 AM - StreetInsider Acumen Pharmaceuticals to Report Third Quarter Financial Results on October 26, 2026 October 19, 2026 4:00 PM - StreetInsider U.S. biotech SMids: Q3 earnings preview October 18, 2026 8:00 PM - StreetInsider Acumen Pharmaceuticals (ABOS) Reiterated at Overweight by Cantor Fitzgerald September 17, 2026 7:28 AM - StreetInsider Form 8-K Acumen Pharmaceuticals, For: Sep 16 September 16, 2026 9:27 AM - SEC Filing Citi Opens New Catalyst Watches September 15, 2026 5:13 AM - StreetInsider Acumen Pharmaceuticals to Hold Virtual Investor Day on September 16, 2026 September 10, 2026 4:00 PM - StreetInsider Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences September 2, 2026 4:00 PM - StreetInsider Form S-8 Acumen Pharmaceuticals, August 12, 2026 4:24 PM - SEC Filing Form 10-Q Acumen Pharmaceuticals, For: Jun 30 August 12, 2026 4:14 PM - SEC Filing Acumen Pharmaceuticals, Inc. (ABOS) Misses Q2 EPS by 9c August 12, 2026 7:44 AM - StreetInsider Form 8-K Acumen Pharmaceuticals, For: Aug 12 August 12, 2026 7:03 AM - SEC Filing Acumen Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Highlights August 12, 2026 7:00 AM - StreetInsider Acumen Pharmaceuticals to Report Second Quarter Financial Results on August 12, 2026 August 5, 2026 4:00 PM - StreetInsider Full Article List